Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Geographical [Axis] UNITED STATES UNITED KINGDOM Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Finite-Lived Intangible Assets by Major Class [Axis] Licensing Agreements [Member] Long-Lived Tangible Asset [Axis] Machinery and Equipment [Member] Leasehold Improvements [Member] Furniture and Fixtures [Member] Computer Equipment [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Sales Agreement [Member] Loan and Security Agreement [Member] Debt Instrument [Axis] Tranche 1 [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Related and Nonrelated Parties [Axis] Department of Veterans Affairs and Department of Defense [Member] Contract with Customer, Sales Channel [Axis] United States Rx [Member] TACS TIM [Member] Outside The United States [Member] In License Or Other [Member] General Wellness [Member] Product and Service [Axis] Product [Member] Other Countries [Member] License [Member] JAPAN Financial Instrument [Axis] US Treasury Bond Securities [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Amendment to Lease Agreement [Member] NEW JERSEY Amendment to Lease Agreement [Member] Error Correction, Type [Axis] Error Correction, Other [Member] Revision of Prior Period [Axis] Revision of Prior Period, Adjustment [Member] 2025 Finance Agreement [Member] 2024 Agreement [Member] Long-Term Debt, Type [Axis] Non-Convertible Notes Payable [Member] Convertible Notes Payable [Member] Tranche 2 [Member] Subscription Agreement [Member] Private Agreements [Member] Securities Purchase Agreement [Member] Class of Warrant or Right [Axis] Prefunded Warrants [Member] Sale of Stock [Axis] Registered Direct Offering [Member] PIPE Warrants [Member] Private Placement [Member] Warrant [Member] Award Type [Axis] Stock Purchase Warrants [Member] Antidilutive Securities [Axis] Share-Based Payment Arrangement, Option [Member] Restricted Stock Units (RSUs) [Member] Convertible Debt Securities [Member] Income Tax Jurisdiction [Axis] Domestic Tax Authority [Member] Tax Credit Carryforward [Axis] Research Tax Credit Carryforward [Member] Federal R and Development Credits [Member] GERMANY Plan Name [Axis] 2018 Omnibus Equity Incentive Plan [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Employee Stock [Member] Restricted Stock and Deferred Stock [Member] Title and Position [Axis] Non Employee Director [Member] Location, Statement of Income, Balance [Axis] Selling General and Administrative Expense [Member] Research and Development Expenses [Member] Cost of Goods Sold [Member] Exercise Price Range [Axis] Exercise Price Range One [Member] Exercise Price Range Two [Member] Exercise Price Range Three [Member] Segments [Axis] Bioelectronic Innovations Segment [Member] Ownership [Axis] NeuroMetrix, Inc. [Member] Vagus Nerve Society [Member] Brian M Posner [Member] Consulting Agreement [Member] Board of Directors Chairman [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Firm ID Auditor Opinion [Text Block] Auditor Name Auditor Location Statement of Financial Position [Abstract] Assets Current assets: Cash and cash equivalents Marketable securities Accounts receivable, net Inventories Prepaid expenses and other current assets Total current assets Property and equipment, net Operating lease right-of-use assets, net Other assets, net Total assets Liabilities and Equity Current liabilities: Accounts payable Accrued expenses and other current liabilities Current portion of operating lease liabilities Total current liabilities Noncurrent liabilities: Operating lease liabilities, noncurrent Long-term debt Total liabilities Commitments and contingencies (see Note 16) Stockholders’ equity (deficit): Common Stock, par value $0.001 per share; 500,000,000 shares authorized as of December 31, 2025 and 2024; 8,004,416 shares issued and outstanding at December 31, 2025, and 6,650,854 shares issued and outstanding at December 31, 2024 Additional paid-in capital Accumulated deficit Accumulated other comprehensive loss Total stockholders’ equity (deficit) Total liabilities and stockholders’ equity (deficit) Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Net sales Cost of goods sold Gross profit Operating expenses: Research and development Selling, general and administrative Total operating expenses Loss from operations Other (income) expense: Interest and other income Interest expense Other expense Total other expense (income) Loss before income taxes (Provision) benefit from income taxes Net loss Net loss per share of common stock - Basic Net loss per share of common stock - Diluted Weighted average common shares outstanding - Basic Weighted average common shares outstanding - Diluted Net loss Other comprehensive income: Foreign currency translation adjustment Other comprehensive income (loss) Comprehensive loss Statement [Table] Statement [Line Items] Balances Balances, shares Other comprehensive income (loss) Sale of common stock and warrants Sale of common stock and warrants, shares Equity issuance costs Proceeds from the exercise of warrants Proceeds from the exercise of warrants, shares Issuance of common stock in connection with employee stock plans, net of forfeitures Issuance of common stock in connection with employee stock plans, net of forfeitures, shares Share based compensation Options exercised Options exercised, shares Accounts payable settled through common stock Accounts payable settled through common stock, shares Issuance of common stock in connection with Avenue loan Issuance of common stock in connection with Avenue loan, shares Balances Balances, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Stock based compensation Depreciation and amortization Amortization of right of use assets Amortization of debt discount Write-down of licensed devices Inventory reserve charge Increase in provision for credit losses Changes in operating assets and liabilities: Accounts receivable Inventories Prepaid expenses and other assets Accounts payable Accrued expense and other current liabilities Operating lease liabilities Net cash used in operating activities Cash flows from investing activities: Purchase of property and equipment Sale (purchase) of marketable securities Net cash provided by (used in) investing activities Cash flows from financing activities: Sale of common stock and warrants Issuance of long-term debt Debt issuance costs Equity issuance costs Proceeds from exercise of options Proceeds from exercise of warrants Net cash provided by financing activities Effect of changes in exchange rates on cash and cash equivalents Net decrease in cash and cash equivalents Cash and cash equivalents – beginning of year Cash and cash equivalents – end of year Supplemental cash flows disclosures: Proceeds from sale of state net operating losses Interest paid Supplemental schedule of noncash activity: Insurance premium financing Accounts payable settled through common stock and warrants Accounts payable settled through the exercise of warrants Non-cash debt issuance costs Shares issued in connection with Avenue loan Accrued purchases of property and equipment Right-of-use asset and operating lease liability Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Equity Awards Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Aggregate Available Rule 10b5-1 Arrangement Modified [Flag] Non-Rule 10b5-1 Arrangement Modified [Flag] Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Cybersecurity Risk Management, Strategy, and Governance [Abstract] Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Cybersecurity Risk Management Processes Integrated [Flag] Cybersecurity Risk Management Processes Integrated [Text Block] Cybersecurity Risk Management Third Party Engaged [Flag] Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Cybersecurity Risk Board of Directors Oversight [Text Block] Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Role of Management [Text Block] Cybersecurity Risk Management Positions or Committees Responsible [Flag] Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] Material Cybersecurity Incident [Abstract] Material Cybersecurity Incident Nature [Text Block] Material Cybersecurity Incident Scope [Text Block] Material Cybersecurity Incident Timing [Text Block] Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block] Material Cybersecurity Incident Information Not Available or Undetermined [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] The Company Accounting Policies [Abstract] Summary of Significant Accounting Policies Liquidity Credit Risks And Going Concern Liquidity, Credit Risks and Going Concern Revenue from Contract with Customer [Abstract] Revenue Cash and Cash Equivalents [Abstract] Cash, Cash Equivalents and Marketable Securities Fair Value Disclosures [Abstract] Fair Value Measurements Inventory Disclosure [Abstract] Inventory Leases Leases Payables and Accruals [Abstract] Accrued Expenses and Other Current Liabilities Debt Disclosure [Abstract] Long-Term Debt Equity [Abstract] Shareholders’ Equity Earnings Per Share [Abstract] Net Loss Per Share Income Tax Disclosure [Abstract] Income Taxes Share-Based Payment Arrangement [Abstract] Stock Based Compensation Segment Reporting [Abstract] Segment Reporting Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Legal Proceedings Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] Acquisitions Related Party Transactions [Abstract] Related Party Transactions Subsequent Events [Abstract] Subsequent Event Basis of Presentation Principles of Consolidation Use of Estimates Revenue Recognition Cash and Cash Equivalents Concentration of Credit Risk Marketable Securities Accounts Receivable Inventories Property and Equipment Leases Licensed Products Impairment of Long-Lived Assets Stock-based Compensation Income Taxes Research and Development Foreign Currency Translation and Transactions Segment Information Recent Accounting Pronouncements Schedule of Depreciation and leasehold improvement amortization Schedule of Net Sales Disaggregated By Geographic Market Schedule of Net Sales Disaggregated By Geographic Market Schedule of Cash, Cash Equivalents and Marketable Securities Summary of Assets and Liabilities Carried at Fair Value Schedule of Inventories Schedule of Operating Leases Schedule of Future Lease Payments Schedule of Accrued Expenses and Other Current Liabilities Schedule of Notes Payable and Convertible Notes Payable Schedule of Maturities of Long-term Debt Schedule of Stock Purchase Warrants Outstanding Schedule of Common Stock Equivalent from the Computation of Diluted Loss Per Share Schedule of Loss Before Provision For Income Taxes Schedule of Income Tax Provision/(Benefit) Schedule of Deferred income tax Assets and Liabilities Schedule of reconciliation of Income Tax Benefit Schedule of Income Tax Benefit Schedule of Cash Income Taxes Paid Schedule of Stock Compensation Expenses Schedule of Outstanding Stock Options Schedule of Stock Options Outstanding and Exercisable Schedule of Restricted and Deferred Stock Unit Schedule of Option Pricing Model in Valuing Stock Options Granted Schedule of Operating Financial Segment Number of wholly owned subsidiaries Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, estimated useful lives Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] Cash equivalents and marketable securities rate Cash, FDIC insured amount SIPC maximum insured amount SIPC limit insured amount Allowance for credit losses Inventory adjustments Operating lease term Intermediate-life plants Cost of goods sold Licensed devices Inventory write off Number of operating segment Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Net losses Net cash used in operating activities Proceeds from sale of equity securities Debt principal amount Marketable securities Potential cash inflows from issuance of stock Remaining value available for shares issuance Potential securities held by non-affiliates, at fair value Potential securities held by non-affiliates Shares issued, offering price Sale of shares Share price Issuance costs Concentration risk percentage Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Total Net Sales Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table] Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] Cash, cash equivalents, Amortized Cost Cash, cash equivalents, Unrealized Gain Cash, cash equivalents, Unrealized (Loss) Cash, cash equivalents, Fair Value Total marketable securities, Amortized Cost Total marketable securities, Unrealized Gain Total marketable securities, Unrealized (Loss) Total marketable securities, Fair Value Total cash, cash equivalents and marketable securities, Amortized Cost Total cash, cash equivalents and marketable securities, Unrealized Gain Total cash, cash equivalents and marketable securities, Unrealized (Loss) Total cash, cash equivalents and marketable securities, Fair Value Fair Value, off-Balance-Sheet Risk [Table] Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items] Cash and cash equivalents Marketable Securities: U.S. treasury bills Total cash, cash equivalents and marketable securities Fair value of marketable securities Raw materials Work in process Finished goods Total inventory Obsolete inventory reserve LeasesTable [Table] Lessee, Operating Lease, Lease Not yet Commenced, Renewal Term [custom:LesseeOperatingLeaseLeaseNotYetCommencedEffectiveDate] [custom:LesseeOperatingLeaseLeaseNotYetCommencedExpiryDate] Area of Real Estate Property [custom:LesseeOperatingLeaseLeaseNotYetCommencedEffectiveDateForExpansionOfLeasedProperty] Operating lease right of use asset Operating lease liability current Operating lease liability noncurrent Rent expense Operating lease expense Schedule Of Operating Leases Operating leases: Operating lease right of use assets Operating lease liabilities: Noncurrent operating lease liabilities Total operating lease liabilities Operating cash flows Weighted average remaining lease term (in years) Weighted average discount rate Schedule Of Future Lease Payments 2026 2027 2028 2029 2030 2031 and thereafter Total future minimum lease payments Less: Amounts representing interest Total Accrued professional fees Accrued bonuses and incentive compensation Accrued litigation legal fees expense Accrued insurance expense Accrued research and development expenses Accrued vacation and other employee related expenses Accrued tax expenses Accrued purchases of inventory Deferred revenue Accrued acquisition related expenses Other Accrued expenses and other current liabilities Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Face amount Debt term Annual Interest rate Periodic payments Interest expense Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Principal Borrowed Final Payment (3.50%) Total Principal Aggregate Debt Discount Debt Discount Amortization Unamortized Debt Discount Balance Sheet - Net Future payment debt amortization percentage 2026 2027 2028 2029 Total Debt principal amount Additional term loan Debt Maturity date Debt conversion converted instrument, amount Debt conversion price per share Debt conversion price, percentage Closing stock price Debt interest rate, percentage Payments for term loans Debt instrument, description Debt discounts Debt issuance costs settled in shares Interest Expense, debt Potential cash in flows from issuance of stock Share issued Share issued, value Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of Warrants, outstanding beginning Weighted Average Exercise Price, beginning balance Weighted Average Remaining Contractual Term Aggregate Intrinsic Value, beginning balance Number of Warrants, Stock purchase warrants granted Number of Warrants, Exercised Number of Warrants, Expired Number of Warrants, outstanding ending Weighted Average Exercise Price, ending balance Aggregate Intrinsic Value, ending balance Number of Warrants, outstanding Weighted Average Exercise Price, exercisable Weighted Average Remaining Contractual Term, Exercisable Aggregate Intrinsic Value, exercisable Class of Warrant or Right [Table] Class of Warrant or Right [Line Items] Incremental common shares attributable to dilutive effect of call options and warrants Stock issued during period, shares, warrants issued Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Aggregate number of shares issued Shares price per share Shares issued. price per share Offer and sell of common stock, value Number of share issued Proceeds from issuance of common stock Financing fees Warrants to purchase common stock Number of warrants sold Exercise price of warrants Warrants expiration date Aggregate proceeds Proceeds from issuance of securities to legal counsel of entity, net of issuance cost Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  Total common stock equivalents Domestic Foreign Federal State Foreign Total current expense (benefit) Total deferred Total income tax provision (benefit) Net operating loss carryforwards Accrued expenses Fixed assets Intangibles Inventory Inventory reserve Allowance for credit losses Charitable contributions R&D credit Lease liabilities Stock compensation Deferred tax assets Less valuation allowance Total deferred tax assets Prepaid expenses Other Right of use asset Total deferred tax liabilities Deferred tax assets, net Effective Income Tax Rate Reconciliation [Table] Effective Income Tax Rate Reconciliation [Line Items] U.S. federal statutory rate U.S. federal statutory rate Current state and local income taxes, net of federal income tax effect Current state and local income taxes, net of federal income tax effect, rate Deferred state and local income taxes Deferred state and local income taxes, rate Statutory tax rate difference Statutory tax rate difference, rate Changes in valuation allowance Changes in valuation allowance, rate Statutory tax rate difference, rate Foreign eliminations Foreign eliminations, rate Research and development tax credits Research and development tax credits, rate Other Tax credits other, rate Changes in valuation allowance Changes in valuation allowance, rate IRC 162(m) Nontaxable or nondeductible items, IRC 162(m), rate Meals and entertainment Nontaxable or nondeductible items, Meals and entertainment, rate Stock based compensation Nontaxable or nondeductible items, Stock based compensation, rate Sale of New Jersey NOL and R&D tax credits Nontaxable or nondeductible items, Sale of New Jersey NOL and R&D tax credits, rate Acquisition of Nuro Acquisition of Nuro, rate Other Other, rate Income tax provision, rate Statutory rate State tax recovery, net of federal benefit State tax rate change Stock compensation State tax NOL sale Nondeductible expenses Credits Change in valuation allowance for deferred tax assets Income tax benefit, rate Federal State Foreign Cash tax payments Net change in valuation allowance Domestic Net operating loss Accumulated losses Period for cumulative change in ownership Cumulative change in ownership percentage Proceeds from operating activity Research and development credits Research and development credits carried forward years Cash income taxes paid StockCompensationExpensesTable [Table] StockCompensationExpensesLineItems [Line Items] Total expense Number of Options, Outstanding, Beginning Weighted Average Exercise Price, Outstanding, Beginning Weighted Average Remaining Contractual Term, Outstanding Aggregate Intrinsic Value, Outstanding, Beginning Number of Options, Outstanding, Granted Number of Options, Exercised Weighted Average Exercise Price, Exercised Number of Options, Cancelled Weighted Average Exercise Price, Cancelled Number of Options, Expired Weighted Average Exercise Price, Expired Number of Options, Outstanding, Ending Weighted Average Exercise Price, Outstanding, Ending Aggregate Intrinsic Value, Outstanding, Ending Number of Options, Exercisable Weighted Average Exercise Price, Exercisable Weighted Average Remaining Contractual Term, Exercisable Aggregate Intrinsic Value, Exercisable Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Exercise Price Exercise Price Options Outstanding Options Outstanding Weighted Average Remaining Contractual Life (Years) Options Exercisable Number of Shares Nonvested Beginning Number of Shares Nonvested Granted Weighted Average Grant Date Fair Value - Granted Number of Shares Nonvested Vested Weighted Average Grant Date Fair Value - Vested Number of Shares Nonvested Cancelled Weighted Average Grant Date Fair Value - Cancelled Number of Shares Nonvested Ending Fair value at grant date Expected volatility Risk-free interest rate Expected holding period, in years Dividend yield Shares reserved Common stock issued and outstanding percentage Maximum sdditional shares Shares exercise Shares reserved Number of shares reserved Contractual life Unrecognized compensation cost Unrecognized compensation expected to be recognized Vesting period Vesting period Volatility rate Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information [Line Items] Gross profit Variable sales and marketing Fixed sales and marketing General and administrative Total operating expenses Loss from operations Number of reportable segments CommitmentsAndContingenciesDisclosureTable [Table] Preferred stock, par value Merger agreement, description Sale of stock, price per share Sale of stock, consideration received per transaction Related Party Transaction [Table] Related Party Transaction [Line Items] Payment for related party Share based compensation vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights Subsequent Event [Table] Subsequent Event [Line Items] Severance payment Non Rule 10b5 1 Arr Modified Flag. Rule 10b 51 Arr Modified Flag. Stock issued during period value warrants exercised. Stock issued during period shares warrants exercised. Accounts payable settled through common stock. Accounts payable settled through common stock, shares. Amortization of operating lease liability. Payments for proceeds from sale and maturity of marketable securities. Proceeds from sale of state net operating losses. Insurance premium financing. Non-cash debt issuance costs. Accounts payable settled through common stock and warrants. Accounts payable settled through the exercise of warrants. Shares issued in connection with avenue loan. Accrued purchases of property and equipment. Write-down of licensed devices. Number of wholly owned subsidiaries. Sales Agreement [Member] Loan and Security Agreement [Member] Tranche 1 [Member] Remaining shares available for issuance. Department of Veterans Affairs and Department of Defense [Member] Marketable securities amortized cost. Marketable securities unrealized gain. Marketable securities unrealized loss. Amendment to Lease Agreement [Member] Lessee operating lease lease not yet commenced effective date. Amendment to Lease Agreement [Member] Lessee operating lease lease not yet commenced expiry date. Lessee operating lease lease not yet commenced effective date for expansion of leased property. Schedule of Supplemental Balance Sheet Information for Operating Leases [Table Text Block] Accrued legal fees litigation expense current. Accrued research and development expenses current. Accrued purchases. Accrued acquisition related expenses. 2024 Agreement [Member] Non-Convertible Notes Payable [Member] Debt instrument future payment debt amortization percentage. Aggregate debt discount amount. Additional term loan. Tranche 2 [Member] Debt issuance costs settled in shares. Subscription Agreement [Member] Private Agreements [Member] Stock Purchase Warrants [Member] Share based compensation arrangement by share based payment award non option equity instruments expired Share based compensation arrangement by share based payment award non option equity instruments exercisable Share based compensation arrangement by share based payment award equity instruments other than options exercisable in period weighted average grant date fair value Share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average remaining contractual terms exercisable Sharebased compensation arrangement by sharebased payment award equity instruments other than options aggregate intrinsic value exercisable Stock issued during period shares warrants issued Non Employee Director [Member] Fixed sales and marketing. Merger agreement, description. NeuroMetrix, Inc. [Member] Incurred aggregate expenses. Vagus Nerve Society [Member] Deferred tax assets leasing arrangements. Consulting Agreement [Member] Deferred tax liabilities right of use asset. Deferred tax assets inventory reserve. Effective income tax rate reconciliation change in deferred tax assets non deductible items. Effective income tax rate reconciliation change in deferred tax assets meals and entertainment. Effective income tax rate reconciliation change in deferred tax assets stock option. Effective income tax rate reconciliation non deductible expense federal benefit of sale. Effective income tax rate reconciliation non deductible expense acquisition. Domestic Tax Authority [Member] Accumulated noncapital losses. Period for cumulative change in ownership. Cumulative change in ownership percentage. Federal R and Development Credits [Member] Research and development credits carried forward years. Effective deferred income tax rate reconciliation state and local income taxes. Effective current income tax rate reconciliation state and local income taxes. Cash equivalent securities sipc maximum insured amount. Cash equivalent securities sipc maximum cash limit of insured amount. Cash equivalents and marketable securities rate Licensed Products [Policy Text Block] Write off intangible assets net. United States Rx [Member] TACS TIM [Member] Outside The United States [Member] In License Or Other [Member] General Wellness [Member] Rx Gamma Core [Member] Truvaga [Member] In License Or Distributed [Member] Quell [Member] Cash equivalents amortized cost. Cash cash equivalents unrealized gain. Cash cash equivalents unrealized loss. Cash cash equivalents and marketable securities amortized cost. Cash cash equivalents and marketable securities unrealized gain. Cash cash equivalents and marketable securities unrealized loss. Cash cash equivalents and marketable securities. 2025 Finance Agreement [Member] 2018 Omnibus Equity Incentive Plan [Member] Securities Purchase Agreement [Member] Prefunded Warrants [Member] Registered Direct Offering [Member] PIPE Warrants [Member] Number of warrants sold together with another class of warrant each. Exercise Price Range One [Member] Exercise Price Range Two [Member] Exercise Price Range Three [Member] Proceeds from issuance of securities to legal counsel of entity net of issuance cost. Restricted Stock and Deferred Stock [Member] Bioelectronic Innovations Segment [Member] Brian M Posner [Member] Other Countries [Member] Proceeds from repayment of stock options exercised Effective income tax rate reconciliation state and local income tax. Effective income tax rate reconciliation tax credits research and development. Effective income tax rate reconciliation tax credits others. Liquidity Credit Risks And Going Concern Disclosure [Text Block] Deferred state and local income taxes. Deferred state and local income taxes rate. Statutory tax rate difference. Statutory tax rate difference rate. Changes in valuation allowance. Changes in valuation allowance rate. Schedule Of Income Tax Paid [Table Text Block] Inventory write off. Share based compensation arrangement by share Based payment award number of additional shares issuable pursuant to exercise of stock options. Schedule Of Effective Incomes Tax Rate Reconciliation [Table Text Block] Inventory write off licensed devices. Remaining value available for shares issuance. Securities held by non-affiliates. Potential cash inflows from issuance of stock. Location, Statement of Income, Balance [Axis] Selling General and Administrative Expense [Member] Research and Development Expenses [Member] Cost of Goods Sold [Member] Amendment to Lease Agreement [Member] [Default Label] Assets, Current Assets [Default Label] Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity [Default Label] Interest and Other Income Other Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income Tax Expense (Benefit) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Payments to Acquire Property, Plant, and Equipment Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Proceeds from Other Equity Payments of Debt Issuance Costs Payments of Stock Issuance Costs Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect, Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name Lessee, Operating Leases [Text Block] Inventory, Policy [Policy Text Block] Lessee, Leases [Policy Text Block] Income Tax, Policy [Policy Text Block] Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Finite-Lived License Agreements, Gross Cash, Cash Equivalents, and Short-Term Investments Cash and Cash Equivalents, Fair Value Disclosure Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Interest Expense, Operating and Nonoperating Debt Instrument, Unamortized Discount Long-Term Debt, Maturity, Year One Long-Term Debt, Maturity, Year Two Long-Term Debt, Maturity, Year Three Long-Term Debt, Maturity, Year Four Long-Term Debt [Default Label] Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Share based compensation arrangement by share based payment award non option equity instruments exercisable Share based compensation arrangement by share based payment award equity instruments other than options exercisable in period weighted average grant date fair value Sharebased compensation arrangement by sharebased payment award equity instruments other than options aggregate intrinsic value exercisable Current Foreign Tax Expense (Benefit) Current Income Tax Expense (Benefit) Deferred Tax Assets, Inventory Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss Deferred Tax Assets, Gross Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance Deferred Tax Liabilities, Prepaid Expenses Deferred Tax Liabilities, Other DeferredTaxLiabilitiesRightOfUseAsset Deferred Tax Liabilities, Gross Deferred Tax Assets, Net Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRatesStatutoryTaxRateDifference Effective Income Tax Rate Reconciliation, Cross-Border Tax Effect, Percent Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent EffectiveIncomeTaxRateReconciliationChangeInTaxCreditsValuationAllowance EffectiveIncomeTaxRateReconciliationChangeInTaxCreditsValuationAllowancePercent Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent Effective Income Tax Rate Reconciliation, Disposition of Business, Percent Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Effective Income Tax Rate Reconciliation, Percent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent Effective Income Tax Rate Reconciliation, Tax Credit, Percent Income Tax Paid, Federal, after Refund Received Income Tax Paid, State and Local, after Refund Received Income Tax Paid, Foreign, after Refund Received Operating Loss Carryforwards Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant